The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
Here's your 5-point cheatsheet on the nasal vaccine:
The two-drop India-made nasal vaccine, iNCOVACC, will be introduced on the Co-WIN platform this evening.
The vaccine, manufactured by Bharat Biotech, will only be available at private centres for now.
Those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.
In heterologous boosting, a person administered a different vaccine from the one that was used for the primary dose series.
The needle-free vaccine received approval of the Drugs Controller General of India in November for restricted use in an emergency situation.
Advertisement
COMMENTS
Advertisement
Over 30% Covaxin Takers Suffered Health Issues After A Year, Claims Study "A Very Big Source Of Covid Vaccines For World": Bill Gates Praises India India Reports 157 Covid Cases, 2 Deaths In Last 24 Hours Under-Fire Trainee IAS Officer Accuses Pune Collector Of Harassment Trainee IAS Officer Puja Khedkar Recalled To Academy, Training Put On Hold Trump's Vice President Pick Reveals How His Hindu Wife Helped Him NEET UG Counselling: Centre Urges Colleges To Update Seat Information 25-Year-Old Fitness Influencer Bullied Online For Looking "Super Old" Andrew Tate Banned From Leaving Romania Amid Human Trafficking Trial: Court Track Latest News Live on NDTV.com and get news updates from India and around the world.